 - Any clinically significant abnormal findings in physical examination, vital signs, haematology, clinical chemistry, or urinalysis during screeningrun-in period, which, in the opinion of the Investigator, may put the subject at risk because of hisher participation in the study, or may influence the results of the study, or the subjects ability to complete entire duration of the study. 